⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27947141 | 0.73 | LMNA (0.38) | — | |
| SCHEMBL2190750 | 0.70 | TNKS (0.36) | — | |
| SCHEMBL27935635 | 0.70 | KDM4E (0.41) | — | |
| SCHEMBL18593134 | 0.68 | CYP11B1 (0.36) | — | |
| SCHEMBL18593130 | 0.66 | CYP11B1 (0.33) | — | |
| SCHEMBL5354010 | 0.66 | CYP11B1 (0.37) | — | |
| SCHEMBL27656600 | 0.65 | — | — | |
| SCHEMBL27880021 | 0.65 | ALOX5 (0.40) | — | |
| SCHEMBL18592944 | 0.65 | PRKDC (0.40) | — | |
| SCHEMBL27966107 | 0.63 | SORD (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101434604-A | Condensed n-heterocyclic compounds and their use as CRF receptor antagonists | SB PHARMCO INC (IE) | 2009-05-20 | — | — | CN | disclosed |
| CN-1805958-A | fused N-heterocyclic compounds and their use as CRF receptor antagonists | SB PHARMCO INC (PR) | 2006-07-19 | — | — | CN | disclosed |